# Sermorelin FAQ: GHRH(1-29), Sleep, Side Effects, and the Research Record > Sermorelin FAQ: what it is, why it is dosed at night, how it compares to CJC-1295 and ipamorelin, its side effects, and what the studies actually establish. Cited answers. Direct, cited answers to the questions researchers and readers actually ask — including the honest gaps. ## Does sermorelin actually help with sleep, or is it waking me up instead? GHRH promoted slow-wave sleep in healthy men in controlled studies [10], and the sleep-endocrine effect depends on the time of administration [11]. These are research findings in study settings, not a personal-use guarantee; individual experiences in research-user communities vary, and the literature describes a circadian-gated effect rather than a uniform one. ## Why is it recommended to inject sermorelin at night? Endogenous growth hormone is secreted in pulses, most prominently during slow-wave sleep, and GHRH's sleep-endocrine effects are time-of-administration dependent [11]. Bedtime dosing was the protocol used in pediatric and aging trials — for example, 30 mcg/kg/day at bedtime [2]. This is described as a studied protocol, not a personal dosing recommendation. ## When is the best time to take sermorelin? Bedtime administration was used in the pediatric efficacy trial and in aging studies, aligning with the nocturnal GH pulse, and GHRH's sleep-endocrine effect is circadian-dependent [11][2]. This describes study timing, not a use instruction; the record reports what was given when, not a schedule a reader should adopt. ## What is sermorelin? Sermorelin (sermorelin acetate) is a synthetic 29-amino-acid peptide matching the 1-29 N-terminal fragment of growth hormone-releasing hormone (GHRH) — the shortest fragment that retains full GHRH-receptor activity [1]. It is a pituitary GH secretagogue, formerly an FDA-approved pediatric growth-hormone-deficiency drug and now prepared by compounding pharmacies. ## What does sermorelin do to the body? It binds GHRH receptors on anterior-pituitary somatotrophs, activating the cAMP/PKA pathway to stimulate the body's own pulsatile growth-hormone release, which in turn raises hepatic IGF-1 [1]. Because it acts upstream of the pituitary, somatostatin and IGF-1 feedback stay intact, preserving the natural pulsatile pattern of GH secretion. ## Does sermorelin work? In its approved pediatric indication, once-daily subcutaneous GHRH(1-29) accelerated growth in deficient children (height velocity ~4.1 to ~7-8 cm/year) [2]. In older men, 14 days of dosing reversed age-related declines in GH and IGF-1 [3]. Adult anti-aging efficacy is less established — an editorial called secretagogue anti-aging use "not yet ready for prime time" [14]. ## How long does it take for sermorelin to work? Acute growth-hormone release follows a single dose within hours — GH stayed elevated about 3 hours after an intravenous dose [13] — while the aging study measured GH/IGF-1 changes over 14 days [3] and the pediatric growth endpoint was assessed over the first year [2]. These timelines are study endpoints, not personal expectations. ## How does sermorelin compare to CJC-1295? Both act on the GHRH receptor, but native sermorelin has a very short plasma half-life (~10-12 minutes), which motivated longer-acting analogs [13]. CJC-1295 with DAC uses a drug-affinity-complex (albumin-binding) strategy, and PEGylation is another half-life-extension approach for GRF analogs [5]. The mechanism is shared; the duration of action is the difference. ## Sermorelin vs ipamorelin: what is the difference? Sermorelin is a GHRH analog acting on the GHRH receptor; ipamorelin is a growth-hormone-releasing peptide (GHRP) acting on the ghrelin/GHS receptor — a different mechanism [4]. In rats, the GHRPs ipamorelin and GHRP-6 increased bone mineral content [4], an effect attributed to that distinct class rather than to GHRH analogs. ## What is sermorelin used for? Historically it was an FDA-approved prescription product (NDA 020443) to evaluate and treat growth-hormone deficiency and short stature in children, and it was used diagnostically as a GHRH stimulation agent. Adult GH-axis research has examined aging, body composition, sleep, and cognition; those non-pediatric uses are research contexts, not approved indications. ## Does sermorelin burn fat? Direct sermorelin fat-loss trials are limited. The body-composition evidence largely comes from the stabilized GHRH analog tesamorelin and from a cognition trial in which IGF-1 rose and percent body fat fell 7.4% [7]. Pulsatile GH also contributes to fasting lipolysis. These are research findings, not a weight-loss claim. ## Is sermorelin effective for weight loss? No sermorelin study establishes it as a weight-loss treatment. The closest controlled body-composition data come from tesamorelin (a related GHRH analog) and from the GHRH cognition trial that reported a 7.4% reduction in percent body fat [7]. Anti-aging and body-composition marketing outpaces the direct sermorelin evidence. ## Does sermorelin affect testosterone? Sermorelin acts on the GH/IGF-1 axis, not directly on the gonadal axis; the literature here reports GH and IGF-1 outcomes [3] and does not establish a direct testosterone effect. Research-community interest in this link is not supported by a specific sermorelin testosterone finding in the corpus. ## Will sermorelin raise my IGF-1 levels? In healthy older men, GHRH(1-29) twice daily for 14 days produced dose-related increases in GH and IGF-1, with high-dose values no longer differing from young men [3]. A related GHRH analog raised IGF-1 by 117% within the physiologic range in a cognition trial [7]. Reported as study outcomes, not a personal prediction. ## Does sermorelin build muscle? The corpus contains no controlled sermorelin muscle-hypertrophy trial. GH/IGF-1-axis modulation has been discussed in reviews as a candidate strategy against age-related muscle loss (sarcopenia), but that is framing, not proof [15]. Lean-mass claims outpace the direct evidence. ## How does sermorelin differ from direct HGH injections? Sermorelin stimulates the pituitary to release the body's own GH in its natural pulsatile pattern, leaving somatostatin and IGF-1 feedback intact, whereas recombinant GH supplies exogenous hormone directly [1]. An editorial argued the secretagogue route may be more physiologic for adult GH insufficiency [6]. ## Does sermorelin affect the brain? GHRH administration has measurable neuroendocrine effects: in a controlled trial a GHRH analog had a favorable effect on cognition in older adults [7], and GHRH influences slow-wave sleep, the sleep stage tied to nocturnal GH. These are research observations in study populations, not a cognitive-enhancement claim. ## Can sermorelin or GHRH improve cognition in older adults? In a randomized, double-blind, placebo-controlled trial of 152 older adults (including 66 with mild cognitive impairment), 20 weeks of a daily GHRH analog had a favorable effect on cognition (P=0.03; executive function P=0.005), alongside a 117% IGF-1 rise and a 7.4% body-fat reduction [7]. Promising, but a single trial of a related analog — not a treatment claim for sermorelin. ## What are the side effects of sermorelin? Reported adverse effects in studies were generally mild, with injection-site reactions the most common; adverse events were described as mild in the GHRH-analog cognition trial [7]. Because GH and IGF-1 are mitogenic, chronically raising them carries a theoretical oncologic consideration, and long-term adult safety data are limited. This is not medical advice. ## Is 3 months of sermorelin enough? Study durations vary by endpoint: acute GH release appears within hours, GH/IGF-1 shifts were measured over 14 days [3], and the pediatric growth endpoint spanned the first year of therapy [2]. The corpus does not define an adult "course length"; the durations described are study timeframes, not protocols to follow. ## Sermorelin before and after: what changes do studies report? Measured before/after changes include accelerated height velocity in deficient children (~4.1 to ~7-8 cm/year) [2], reversal of age-related GH/IGF-1 declines in older men [3], and — for a related GHRH analog — a 117% IGF-1 increase with a 7.4% body-fat reduction [7]. These are trial outcomes, not personal results. ## How does sermorelin work to stimulate growth hormone production? It binds the GHRH receptor (a class B GPCR) on pituitary somatotrophs, activating Gs/adenylate-cyclase/cAMP/PKA signaling to increase GH gene transcription and pulsatile GH release; downstream, GH drives hepatic IGF-1, while somatostatin and IGF-1 feedback — preserved by this upstream action — keep the pattern pulsatile [1]. --- A night research board of the sermorelin literature — slow-wave sleep, the nocturnal growth-hormone pulse, and the GHRH(1-29) findings pinned and cited, with the body-composition data taped where it belongs as tesamorelin and the empty adult-safety clipping left torn open; no clinic behind the board and nothing here dosed, dispensed, or sold.